4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide

Catalog No. :
ACXGTU612
CAS No. :
24683-25-8
Molecular Formula :
C10H10N2O4S
Molecular Weight :
254.27

IUPAC Name:4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide

4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg97%$1954.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide
IUPAC Name4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide
Molecular FormulaC10H10N2O4S
Molecular Weight254.27
SMILESCN1C(C(N)=O)=C(O)C2=CC=CC=C2S1(=O)=O
InChI KeyBBOFTHBIXOWDMA-UHFFFAOYSA-N
Synonym4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide;Despyridyl Piroxicam (Piroxicam Impurity C);4-Hydroxy-2-Methyl-2H-1,2-benzothiazine-3-carboxaMide 1,1-Dioxide;PiroxicaM IMpurity C;Meloxicam Impurity 14;Imp. C (EP):4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide1,1-Dioxide;4-Hydroxy-2-methyl-2H-1,2-benzothia;2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-, 1,1-dioxide
CAS No.24683-25-8

Synthetic Route by SureRoute

1. ACXGTU612 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTWIA836 route compound structure diagram
    ACTWIA83635511-15-0 In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACXGTU612 route product structure diagram
    ACXGTU61224683-25-8
Inquiry

2. ACXGTU612 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXGTU612 route product structure diagram
    ACXGTU61224683-25-8
Inquiry

Comments (0)